Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBF-1681 for Iron Deficiency Anemia in NDD-CKD
NCT04543812Phase 3Completed
- Sponsor
- Panion & BF Biotech Inc.
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) comparing PBF-1681 with Placebo (2 arms). Primary endpoint: Hemoglobin at 16 weeks. Started Oct 2020; status: completed.
02
Drugs
ferric citrate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04543812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04543812.